Suspended

Predictive Value of C-Reactive Protein in Acute Diverticulitis

0 criteria met from your profileSee at a glance how your profile meets each eligibility criteria.
What is being collected

Data Collection

Collected from today forward - Prospective
Other
Who is being recruted

From 18 to 90 Years
+2 Eligibility Criteria
See all eligibility criteria
How is the trial designed

Case-Only

Examining characteristics of individuals with a disease in order to identify genetic or environmental factors contributing to the condition.
Observational
Study Start: April 2013
See protocol details

Summary

Principal SponsorCorporacion Parc Tauli
Study ContactMORA L. LAURA, MDMore contacts
Last updated: April 10, 2013
Sourced from a government-validated database.Claim as a partner

Study start date: April 1, 2013

Actual date on which the first participant was enrolled.

A prospective observational study. All the patients with TC-diagnosis of acute diverticulitis (AD) had a C-reactive protein (PCR) in the initial blood test. The investigators will predict evolution of AD with the PCR initial.

Principal SponsorCorporacion Parc Tauli
Study ContactMORA L. LAURA, MDMore contacts
Last updated: April 10, 2013
Sourced from a government-validated database.Claim as a partner

Protocol

This section provides details of the study plan, including how the study is designed and what the study is measuring.
Design Details

30 patients to be enrolled

Total number of participants that the clinical trial aims to recruit.

Case-only

These studies focus only on individuals who have a specific disease. Researchers examine patterns—often genetic or environmental—to uncover what might be linked to the condition.

Eligibility

Researchers look for people who fit a certain description, called eligibility criteria: person's general health condition or prior treatments.
Criteria

Any sex

Biological sex of participants that are eligible to enroll.

From 18 to 90 Years

Range of ages for which participants are eligible to join.

Healthy volunteers not allowed

If individuals who are healthy and do not have the condition being studied can participate.

Criteria

1 inclusion criteria required to participate
Acute Diverticulitis

1 exclusion criteria prevent from participating
Other Abdominal Pathologies

Study Plan

Find out more about all the medication administered in this study, their detailed description and what they involve.
Treatment Groups
Study Objectives

One single intervention group is designated in this study

This study does not include a placebo group 

Treatment Groups

Study Objectives

Primary Objectives

Study Centers

These are the hospitals, clinics, or research facilities where the trial is being conducted. You can find the location closest to you and its status.

This study has 4 locations

Corporacion Parc Tauli

Sabadell, SpainOpen Corporacion Parc Tauli in Google Maps

Corporacion parc tauli

Sabadell, Spain

Corporacion Parc Tauli

Sabadell, Spain

Corporacion Parc Tauli

Sabadell, Spain
Suspended4 Study Centers